The European drug regulator stated that “unusual blood clots” should be listed as a “very rare” side effect of Oxford-astrazeneca Covid vaccine.
The European Medicines Agency (EMA) stated that it had arrived at its conclusion on the coronavirus Jab after taking into account all available evidence.
Ministers of Health at the European Union (EU) have been informed that the announcement would have an “immediate impact on vaccination plans” and “confidence in vaccines”, according to an EU document observed by Reuters News Agency.
It came as British Government Advisers said that the British aged 18 to 29 will be offered an alternative to the Oxford-Astrazeneca vaccine, where available.
EMA reminded health professionals and people who receive the vaccine to become aware of the possibility of very rare cases of blood clots combined with low blood platelet levels occurring within two weeks of vaccination.
That so far, most reported cases have occurred in women under the age of 60.
Subscribe to Our Newsletter Here : Get the latest News Sent to You
People who have received the vaccine should request medical assistance immediately if they develop the following symptoms:
- Shortness of breath
- Chest pain
- Swelling in the leg
- Persistent stomach pain
- Severe and persistent headaches
- Blurred vision
- Tiny blood spots under the skin beyond the injection site
EMA’s conclusion followed a thorough examination of 86 cases of blood clots – 18 of which were fatal – on March 22 of 25 million people who received the vaccine.